Nymox enlarged prostate drug fails two Phase III studies

Nymox bigger prostate medicine falls short two Phase III researches Nov 2, 2014 – 23:59 GMT Nymox Drug Corp has experienced an enormous problem with the news that its investigational therapy for speculative increased prostate drug has actually fallen short in two late-stage tests. The US company noted that 2 [...] Read More